The patient, a 19-year-old university student who has asked to remain anonymous, had a sample of testicular tissue removed and cryopreserved in 2023, before he underwent a bone marrow transplant to treat a serious blood disorder. Bone marrow transplantation requires high-dose chemotherapy, a regimen that can permanently destroy the spermatogonial stem cells responsible for sperm production throughout adult life. Three years after completing his treatment, clinical tests confirmed that no sperm were present in his semen, a finding that would previously have left him with no options at all.

In August 2026, surgeons reimplanted small pieces of his preserved tissue in the hope that the stored stem cells would recolonise the testis and resume spermatogenesis, the complex biological process by which sperm cells mature. The young man has recovered well and will now be monitored closely. After eight months, a sample of the transplanted tissue will be surgically removed and examined under the microscope to determine whether sperm have actually been produced. That checkpoint will provide the first concrete evidence of whether the procedure has worked in a UK patient.

The scientific logic behind the approach rests on the biology of the testis itself. Within the seminiferous tubules, spermatogonial stem cells divide and differentiate from puberty onwards, generating the successive generations of cells that ultimately become mature sperm. Chemotherapy agents and radiotherapy are highly toxic to these rapidly dividing lineages, and in prepubertal boys the tissue has not yet begun producing sperm at all. Freezing small fragments of tissue before treatment therefore preserves the only cells capable of restarting sperm production later in life, even though the tissue at the time of storage is biologically immature.

This is precisely why the technique matters for a group that existing medicine cannot serve. Semen cryopreservation is a well-established fertility preservation option for adolescent and adult males, who can simply bank a sperm sample before starting treatment. Prepubertal boys, however, do not yet produce sperm, so there has been no established clinical method to restore their fertility after sterilising therapies. More than 1,200 patients in the UK and around 3,100 worldwide have now had testicular tissue stored for potential future clinical use, creating a growing cohort of young people who may one day return to clinics like the one in Edinburgh hoping to use it.

The Edinburgh testicular project, established in 2015 with funding from the charity Children with Cancer UK, has grown over ten years into a national programme for tissue banking and translational research. In 2024 the charity provided further funding specifically to support the transplantation study that made the August 2026 operation possible. The programme’s design reflects a deliberately cautious, evidence-first strategy: tissue is collected and frozen under rigorous clinical protocols, while the transplantation step is evaluated as a research procedure before it can be offered as routine care.

Crucially, the Edinburgh team did not move into human transplantation without prior animal evidence. Studies in non-human primates demonstrated that testicular tissue frozen before sterilising chemotherapy could be transplanted back successfully, with the grafts producing mature sperm that were subsequently used in assisted reproduction to achieve a live birth. That result provided the proof of principle that cryopreserved immature tissue retains its developmental potential after thawing and reimplantation, and that the resulting sperm can lead to a healthy offspring. The primate work also helped define the surgical and biological parameters, such as graft placement and the time needed for blood vessels to regrow into the transplanted tissue and support maturation of the stem cells.

The first demonstration in a human patient came earlier this year in Belgium, where testicular tissue frozen before puberty was successfully transplanted back and subsequently produced mature sperm. That landmark result confirmed that the animal findings could be translated into people, and it set the stage for the Edinburgh procedure as the second reported worldwide. The Belgian case involved tissue preserved in childhood, while the UK patient had tissue stored as an older adolescent, illustrating that the technique may eventually serve a broad age range of patients whose fertility is threatened by treatment.

Study lead Rod Mitchell, Professor of Developmental Endocrinology at the University of Edinburgh’s Institute for Regeneration and Repair and Consultant Paediatric Endocrinologist at NHS Lothian, described the operation as a major advance. He noted that ten years ago the team began freezing and storing pieces of testicular tissue from boys before they started chemotherapy, and that some of those young men are now returning to explore their fertility options. Tracey Gillies, Medical Director at NHS Lothian, called the procedure a landmark step for young people whose future fertility may be compromised by the treatment they need to overcome serious illness, highlighting the collaboration between NHS clinicians and university researchers as an example of world-leading clinical work.

For the patient himself, the procedure carries a significance that extends beyond the laboratory. In a statement, he said that fertility was something he had struggled with personally for a long time, and that he had slowly begun to accept he might never have children of his own. He described the operation as giving him genuine hope for the future, acknowledging that no one yet knows whether it will work but emphasising that even the possibility means more than he can put into words. He also expressed the hope that taking part in the research will help other young people in the same position one day share that hope. Whether the transplanted tissue produces sperm will become clear at the eight-month examination, and even a positive result would likely still require assisted reproduction rather than natural conception. But the procedure has already established a UK-first clinical pathway, and if the Edinburgh team’s careful decade of groundwork pays off, thousands of stored tissue samples around the world could one day offer the same possibility to survivors of childhood and adolescent illness.

Subject of Research: Transplantation of cryopreserved testicular tissue to restore fertility after sterilising cancer treatment

Article Title: UK first as frozen testicular tissue transplanted to help restore fertility

Article References: UK first as frozen testicular tissue transplanted to help restore fertility. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: testicular tissue transplantation, fertility preservation, spermatogonial stem cells, chemotherapy, cryopreservation, University of Edinburgh, NHS Lothian, pediatric oncology, male infertility, bone marrow transplant, assisted reproduction, clinical trial

The stage for this balancing act is spermatogenesis, the process by which spermatozoa are produced through the differentiation of spermatogonial stem cells, or SSCs, and their subsequent spermatogenic descendants. In the male gonads of mice, the model organism at the heart of most of this research, epigenetic regulation is central to controlling this process. Epigenetic regulation, broadly defined, refers to the layer of chemical tags and chromatin structures that governs which parts of the genome are active without altering the underlying DNA sequence. As male germ cells progress through spermatogenesis, their transcriptional activity changes dynamically to enable the transition from mitotically dividing SSCs to meiotic spermatocytes, and then through the profound morphological changes necessary to generate spermatozoa. Each of these steps demands a wholesale reconfiguration of the epigenetic landscape.

The review emphasizes that an ensemble of fine-tuned epigenetic factors and mechanisms regulates this transcriptional activity. These include DNA methylation, the addition of methyl groups to cytosine bases; a rich vocabulary of histone modifications, such as the methylation and acetylation marks on histone H3 that the authors catalog by residue and modification type, including H3K4me1/2/3, H3K27ac, H3K27me3 and H3K9me2; and the action of architectural proteins such as CTCF and its germline-specific relative BORIS, which organize the genome into three-dimensional domains known as topologically associated domains. Enzyme families including DNA methyltransferases, histone acetyltransferases, histone deacetylases, histone methyltransferases and lysine demethylases write and erase these marks, while polycomb repressive complexes 1 and 2 help lock down inappropriate gene expression. Modern mapping technologies, from chromatin immunoprecipitation followed by sequencing to ATAC assays for accessible chromatin, CUT&RUN, CUT&Tag and chromosome conformation capture methods, have made it possible to chart these features at ever finer resolution.

The first act of the drama concerns the SSCs themselves. These stem cells must maintain their own population through self-renewal while also committing to differentiation, and the review describes how epigenetic plasticity underpins this choice. Regulatory factors such as the promyelocytic leukemia zinc finger, PLZF, are associated with the stem cell state, and the chromatin of undifferentiated spermatogonia remains comparatively open and responsive, allowing these cells to respond to cues that tip them toward either maintenance or differentiation. As differentiating spermatogonia emerge, the epigenome begins to shift, priming the cells for the sweeping changes ahead. This plasticity is not a flaw but a feature: without it, the germline could not replenish itself across the reproductive lifespan of the animal.

The second act is the mitosis-to-meiosis transition, arguably the most dramatic reprogramming event in the entire process. Cells that have been faithfully copying themselves through mitosis must now halve their genetic content, and their transcriptional program must change accordingly to support entry into meiosis as spermatocytes. The review describes how epigenetic mechanisms coordinate this switch, with changes in DNA methylation patterns, histone marks and chromatin accessibility working in concert to silence mitotic programs and activate the meiotic machinery. Super-enhancers, clusters of regulatory elements that drive high-level expression of key identity genes, are part of this coordination, as are changes in the three-dimensional folding of the genome that bring distant regulatory elements into contact with their target genes.

The third act is post-meiotic maturation, and it is here that the tension between flexibility and stability becomes most visible. Round spermatids must transform into elongated spermatozoa, a process that involves replacing the majority of histones with protamines, the small, highly basic proteins that allow DNA to be packed with extraordinary density into the head of the sperm. Transition proteins bridge this exchange. This near-total repackaging means that most histone-based regulatory information is dismantled, yet the review highlights that some epigenetic marks are stably maintained in spermatozoa. DNA methylation, in particular, must be preserved through this upheaval, and a subset of retained histones and their modifications may carry information forward as well.

That preserved information matters beyond the sperm itself. The review describes how some epigenetic marks maintained in spermatozoa can, in some cases, be passed to the embryo and influence offspring phenotypes. This possibility, which connects germline epigenetics to the broader and often debated field of intergenerational inheritance, gives the stability side of the double-edged sword its full weight. Marks that survive the protamine exchange and the early embryonic reprogramming that follows fertilization represent a channel through which the paternal germline can, in principle, shape the development of the next generation. The Mansuy laboratory has a long history of work on how environmental experience can leave traces in the germline, and this review situates the molecular machinery of the postnatal male germline within that larger question.

The sword cuts both ways, however, and the review is explicit about the consequences of disruption. When the fine-tuned ensemble of epigenetic factors goes awry, the result can be sub- or infertility. Spermatogenesis is a long, staged process with many checkpoints, and errors in DNA methylation establishment or maintenance, misregulated histone modification, or faulty chromatin remodeling at any stage can compromise the production or quality of spermatozoa. The germline’s need for plasticity makes it inherently vulnerable: the very openness that allows stem cells to self-renew and differentiating cells to reprogram their transcription also exposes the genome to instability. Conversely, excessive rigidity would prevent the transitions that spermatogenesis requires. Hence the double-edged sword of the title.

The review also draws attention to the germline’s relationship with transposable elements, the mobile genetic sequences, including endogenous retroviruses and LINE-1 elements, that litter the mammalian genome. Keeping these elements silent is a perennial task in germ cells, where their activity would be especially damaging because changes would be heritable. Epigenetic silencing mechanisms, particularly DNA methylation and repressive histone marks, are deployed against these sequences throughout the postnatal stages, adding another layer to the stability mandate. The authors’ abbreviation list, spanning everything from fluorescence-activated cell sorting to unit-gravity sedimentation cell separation, hints at the technical sophistication of the field, which now combines cell-type purification with genome-wide epigenomic profiling to dissect individual stages of spermatogenesis that were once studied only in bulk tissue.

What emerges from Schöpp and Mansuy’s synthesis is a picture of the postnatal male germline epigenome as a system in constant, controlled motion. From the formation and differentiation of SSCs, through the mitosis-to-meiosis transition, to post-meiotic maturation and the final packaging of the sperm genome, epigenetic marks are written, erased, rewritten and selectively preserved. The review closes by outlining open questions about how these processes are coordinated across developmental stages and what their biological importance is, acknowledging that the field is still assembling the full choreography. How the three-dimensional organization of the genome is reconfigured at each transition, how retained histones are chosen and what they carry, and how the balance between flexibility and stability is enforced at the molecular level all remain active frontiers. For researchers interested in fertility, in developmental biology, and in the mechanisms by which information travels from one generation to the next, the postnatal male germline has become one of the most instructive systems available, and this review provides a timely map of where the field stands and where it must go next.

Subject of Research: Epigenetic regulation of spermatogenesis in the postnatal male germline

Article Title: The epigenome of the postnatal male germline: A double-edged sword between flexibility and stability

Article References: Schöpp, T., & Mansuy, I. M. (2026). The epigenome of the postnatal male germline: A double-edged sword between flexibility and stability. Cellular and Molecular Life Sciences. https://doi.org/10.1007/s00018-026-06427-3

Image Credits: AI Generated

DOI: 10.1007/s00018-026-06427-3

Keywords: epigenetics, male germline, spermatogenesis, spermatogonial stem cells, DNA methylation, histone modifications, chromatin, spermatozoa, meiosis, infertility, transposable elements, intergenerational inheritance

Every cell in the human body harbors an identical DNA blueprint, yet the diversity in cell types arises from the distinct ways DNA is folded, packaged, and regulated. Within the nucleus, approximately two meters of DNA strand must be intricately folded to fit into a microscopic space, a process meticulously organized into three-dimensional domains delineated by boundary regions known as insulation. These boundaries prevent cross-talk between different genetic elements, ensuring precise gene expression patterns. Cohesin complexes, multi-protein rings known for holding sister chromatids together during cell division, have recently gained recognition as vital architects of these boundaries, mediating chromatin looping and genome organization.

Before this study, two primary cohesin complexes were characterized: mitotic cohesins comprising STAG1 or STAG2 paired with RAD21, active during the cell cycles that produce identical daughter cells; and meiotic cohesins containing STAG3 partnered with REC8 or RAD21L, operative during gamete formation. However, SSCs, the stem cells responsible for sustaining spermatogenesis, seemed to challenge these categorizations. These cells feature uniquely weak DNA boundary structures, an unusual characteristic that hinted at the possibility of unexplored regulatory mechanisms.

In pursuit of elucidating the molecular underpinnings of SSC-specific DNA organization, the Kyoto University team employed state-of-the-art immunoprecipitation followed by mass spectrometry to map cohesin components within in vitro cultured SSCs. Their results were startling: instead of associating with STAG1 or STAG2 as conventional mitotic cells do, RAD21 partnered predominantly with STAG3. This unexpected pairing revealed a heretofore unknown mitotic cohesin complex, now named STAG3-cohesin, shattering the dogma that positioned STAG3’s function solely within meiotic contexts.

To interrogate the functional consequences of this novel complex, the scientists engineered genetically modified SSC lines. One variant was deficient in STAG3, while another expressed STAG3 exclusively, lacking STAG1 and STAG2. Through meticulous chromatin conformation analyses, the team demonstrated that STAG3-cohesin is responsible for the distinctive weak boundary formation in SSC chromatin architecture. Crucially, SSCs devoid of STAG3 failed to transition efficiently from stem cell status to differentiated germ cells, indicating that STAG3 not only sculpts the nucleome but is indispensable for proper sperm development.

Extending beyond basic biology, the implications of STAG3’s mitotic role ripple into human health and disease. Leveraging extensive transcriptomic datasets, the researchers established that STAG3 exhibits high expression levels in human immune B cells and, notably, in B-cell lymphomas — cancers derived from malignant B lymphocytes. Functional assays revealed that targeted inhibition of STAG3 in these cancer cells significantly impeded their proliferative capacity in vitro, indicating a promising therapeutic target in oncology.

This discovery of STAG3-cohesin as a distinct mitotic complex with dual roles in germline development and cancer pathophysiology invites a reevaluation of cohesin biology. Unlike classical cohesins, which form robust DNA boundaries, STAG3-cohesin creates weaker, more flexible insulation zones, potentially facilitating the dynamic chromatin remodeling essential for SSC differentiation. This finding advances the understanding of how subtle modulation of chromatin topology can influence cell fate decisions, particularly at the critical juncture between mitosis and meiosis.

The stakes of this research are profound. Male infertility remains a global challenge with complex underlying causes, many of which relate to defects in germ cell development. Illuminating the role of STAG3-cohesin offers a tangible molecular mechanism that could underpin certain infertility cases linked to SSC dysfunction. Furthermore, the connection of STAG3 to B-cell lymphoma progression opens novel avenues for cancer research targeting cohesin complexes, a class of proteins not traditionally exploited in cancer therapeutics.

Beyond immediate clinical applications, the study catalyzes fundamental questions about genome regulation. How does the presence of STAG3 in mitotic cells alter the cohesin-mediated chromatin loop formation? What regulatory pathways control the switch between the usage of STAG3-cohesin and canonical cohesins during stem cell differentiation? Addressing these will be pivotal in decoding the complex choreography of the male germline nucleome.

The Kyoto University team, led by Professor Mitinori Saitou, combined sophisticated biochemical techniques, genetic engineering, and computational biology to dissect the chromatin landscape of SSCs. Their integrative approach exemplifies how interdisciplinary methods can unravel previously inaccessible layers of cellular regulation. Published in the prestigious journal Nature Structural & Molecular Biology, this study sets a new standard for investigations into the molecular architecture of stem cells.

Looking forward, the scientific community anticipates that research into STAG3’s functions will expand into other cell types, potentially revealing broader roles for this cohesin variant in human development and disease. Its unexpected presence and function in immune cells hint at an intricate network of genome regulation that transcends traditional boundaries of cell identity and division modes.

In sum, the revelation of STAG3-cohesin reshapes our conception of the mitotic machinery within spermatogonial stem cells, linking genome structure remodeling directly to stem cell fate and fertility. At the intersection of structural biology, stem cell research, and oncology, this discovery heralds a new chapter in understanding the dynamic interplay between chromatin architecture and cellular function, with promising translational potential in medicine.

Subject of Research: Cells

Article Title: The mitotic STAG3–cohesin complex shapes male germline nucleome

News Publication Date: August 25, 2025

Web References:

• Institute for the Advanced Study of Human Biology (ASHBi), Kyoto University
• Journal article DOI

References:

• Saitou, M., Nagano, M., Hu, B. et al. The mitotic STAG3–cohesin complex shapes male germline nucleome. Nature Structural & Molecular Biology (2025).

Keywords: Gametogenesis, Chromatin